Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Quarterly results
Inv. presentation
Asset disposition
|
|
RAPT Therapeutics, Inc. (RAPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $15.77, valued at
$39.4k
|
|
| 08/22/2023 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $18.92, valued at
$47.3k
|
|
| 08/03/2023 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Exercised 460 options to buy
@ $12, valued at
$5.5k
|
|
| 05/25/2023 |
4
| Robbins Wendye (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
| 05/25/2023 |
4
| RIEFLIN WILLIAM JL (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
| 05/25/2023 |
4
| Lyons-Williams Lori (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
| 05/25/2023 |
4
| Kozick Linda (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
| 05/25/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
| 05/25/2023 |
4
| Giordano Michael F (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $29.62, valued at
$148.1k
|
|
| 03/06/2023 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Exercised 460 options to buy
@ $12, valued at
$5.5k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $30, valued at
$150k
|
|
| 01/20/2023 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $25.56, valued at
$127.8k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 742 shares
@ $21.966, valued at
$16.3k
|
|
| 12/30/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $18.03, valued at
$90.2k
|
|
| 11/29/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $17.87, valued at
$89.4k
|
|
| 11/03/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $22.32, valued at
$111.6k
|
|
| 10/14/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $21.52, valued at
$43k
|
|
| 10/04/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Exercised 347 options to buy
@ $6.3, valued at
$2.2k
Exercised 460 options to buy
@ $12, valued at
$5.5k
|
|
| 09/06/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Exercised 348 options to buy
@ $6.3, valued at
$2.2k
Exercised 460 options to buy
@ $12, valued at
$5.5k
|
|
| 08/31/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $28.13, valued at
$70.3k
|
|
| 08/15/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Exercised 347 options to buy
@ $6.3, valued at
$2.2k
Exercised 460 options to buy
@ $12, valued at
$5.5k
|
|
| 07/13/2022 |
4
| HO WILLIAM (Chief Medical Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $19.95, valued at
$39.9k
Exercised 1,041 options to buy
@ $6.3, valued at
$6.6k
Exercised 1,381 options to buy
@ $12, valued at
$16.6k
|
|
| 05/27/2022 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Bought 1,837 shares
@ $12.4549, valued at
$22.9k
Bought 63 shares
@ $12.4549, valued at
$784.7 |
|
| 05/27/2022 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Bought 1,837 shares
@ $12.4549, valued at
$22.9k
Bought 63 shares
@ $12.4549, valued at
$784.7 |
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|